NCT06358040

Brief Summary

The opioid crisis continues to plague the United States. While great strides have been made nationwide to decrease overprescribing, improvements are still needed to appropriately educate patients on the safe and responsible use, storage and disposal of opioids. Pain after surgery is often treated with opioid medications. Opioid medications can have side effects. Some side effects are relatively minor (constipation, nausea, vomiting), while others are more severe (sedation, abnormal breathing, etc.) and can lead to serious illness or death. Opioid pain medications when used the wrong way may also be addictive. Due to theses side effects, sometimes patients feel uncomfortable about taking these medications, and doctors prescribe them very cautiously. However, when used properly and safely, opioid pain medications are excellent pain relievers. Addinex, a technology company, has developed a device to help patients take opioids more safely. In this study the investigators aim to enroll a total of 30 patients who undergo spine surgery. Half will be randomly assigned to receive a standard pill bottle with opioids at discharge and will download a mobile app so that they can record their daily pain scores and the number of opioids they take for two weeks after surgery. The other half will receive the new opioid dispenser filled with opioids and a mobile app that generates a passcode that opens that device only at designated times. For this group of patients, every time the patient wants to take an opioid, they need to go to the app, enter their pain score before the app generates a passcode. The investigators will be tracking all study patients' opioid use and pain scores for the two weeks after surgery, will count how many pills they have left over 14 days after their surgery during a live telehealth session, and ask patients how they liked using the device. Results from this study will help understand if the Addinex device could potentially be useful to patients in the future after surgeries as opposed to typical pill bottles.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
2mo left

Started Oct 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 5, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 10, 2024

Completed
2.5 years until next milestone

Study Start

First participant enrolled

October 1, 2026

Expected
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

December 8, 2025

Status Verified

November 1, 2025

Enrollment Period

Same day

First QC Date

April 5, 2024

Last Update Submit

December 2, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cumulative Opioid Consumption at Postoperative Day 14 (POD14)

    Cumulative Opioid Consumption at Postoperative Day 14 (POD14) following lumbar decompression (microdiscectomy/laminectomy), expressed as number of tablets and morphine equivalents (MED in mg) and collected via app starting at discharge to 14 days later.

    Hospital Discharge to Postoperative Day 14

Secondary Outcomes (7)

  • NRS pain intensity ratings

    PACU; Daily after Hospital Discharge: Postoperative Day 1 up to Postoperative Day 14

  • Patient satisfaction with the app and with the dispensing device

    Postoperative Day 14

  • Frequency of reported difficulties using the device

    Daily up to Postoperative Day 14

  • Frequency of reported difficulties using the app

    Daily up to Postoperative Day 14

  • Opioid prescription refill rates

    6 weeks postoperatively

  • +2 more secondary outcomes

Study Arms (2)

Standard Opioid Pill Bottle with App

ACTIVE COMPARATOR
Other: AppOther: Standard Opioid Pill Bottle

Opioid-Dispensing Device with App

EXPERIMENTAL
Device: Opioid-Dispensing DeviceOther: App

Interventions

Addinex Opioid-Dispensing Device

Also known as: Addinex
Opioid-Dispensing Device with App
AppOTHER

Addinex App

Also known as: Addinex
Opioid-Dispensing Device with AppStandard Opioid Pill Bottle with App

Standard Opioid Pill Bottle

Standard Opioid Pill Bottle with App

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • opioid-naive patients or intermittent opioid users within 3 months of scheduled surgery
  • At least 18 years old
  • presenting for primary elective one-level lumbar laminectomy and/or discectomy via posterior approach with participating surgeon
  • planned discharge on day of surgery/23 hour admission
  • planned discharge to home

You may not qualify if:

  • patients with opioid-tolerance
  • patients without a smart-phone or without the ability to perform Telehealth visits
  • patients unable to utilize the medication dispensing device
  • patients presenting for other surgeries/surgeries with combined anterior/lateral approaches
  • patient refusal
  • allergy or intolerance to opioids
  • planned admission after surgery
  • planned discharge disposition to nursing facility or skilled rehabilitation
  • planned use of or preference for opioid other than oxycodone
  • patients who are pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital for Special Surgery

New York, New York, 10021, United States

RECRUITING

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Amyloid

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Multiprotein ComplexesMacromolecular SubstancesProteinsAmino Acids, Peptides, and Proteins

Study Officials

  • Vladimir Kramskiy, MD

    Hospital for Special Surgery, New York

    PRINCIPAL INVESTIGATOR

Central Study Contacts

William Chan, MEng

CONTACT

Alexandra Sideris, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 5, 2024

First Posted

April 10, 2024

Study Start (Estimated)

October 1, 2026

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

December 8, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices) will be shared.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Beginning 9 months and ending 36 months following article publication
Access Criteria
For researchers who provide a methodologically sound proposal and analyses to achieve aims in the approved proposal. Proposals should be directed to siderisa@hss.edu. To gain access, data requestors will need to sign a data access agreement.

Locations